BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1282 related articles for article (PubMed ID: 18544969)

  • 1. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
    Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
    Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie?
    Müller V; Pantel K
    Cytotherapy; 2005; 7(6):478-82. PubMed ID: 16306009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and disseminated tumor cells in the management of breast cancer.
    Ross JS; Slodkowska EA
    Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.
    Hayashi N; Yamauchi H
    Breast Cancer; 2012 Apr; 19(2):110-7. PubMed ID: 21643809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and management of bone marrow micrometastases in breast cancer.
    Osborne MP; Rosen PP
    Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cells in breast cancer--review.
    Vertakova KB; Sanislo L; Spanik S; Svec J; Ondrus D
    Klin Onkol; 2010; 23(2):86-91. PubMed ID: 20465086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
    Fehm T; Braun S; Muller V; Janni W; Gebauer G; Marth C; Schindlbeck C; Wallwiener D; Borgen E; Naume B; Pantel K; Solomayer E
    Cancer; 2006 Sep; 107(5):885-92. PubMed ID: 16874814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of disseminated tumor cells in the bone marrow of patients with primary breast cancer--results of a standardized follow-up.
    Schindlbeck C; Pfab G; Jueckstock J; Andergassen U; Sommer H; Janni W; Friese K; Rack B
    Anticancer Res; 2011 Sep; 31(9):2749-55. PubMed ID: 21868516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of bone marrow micrometastases in women with breast cancer.
    Braun S; Auer D; Marth C
    Cancer Invest; 2009 Jul; 27(6):598-603. PubMed ID: 19557580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
    Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells in breast cancer.
    Banys M; Müller V; Melcher C; Aktas B; Kasimir-Bauer S; Hagenbeck C; Hartkopf A; Fehm T
    Clin Chim Acta; 2013 Aug; 423():39-45. PubMed ID: 23623805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.